Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)
Clinical trial NCT06287567 · COMPLETED
Trial details
- NCT number
- NCT06287567
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-17
- Primary completion
- 2024-11-13
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.